Drug Trial Radar · NCT00862459
Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Last checked: Nov 20, 2026Latest source record: Jan 13, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
237
Actual
Start
Aug 2005
Primary completion
Mar 2007
Study completion Mar 2007
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Mar 17, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Gadavist when used for taking images of the brain and spine. The results of the MRI with Gadavist Injection will be compared to the results of MR images taken without contrast and with the results of the MR images taken with OptiMARK.
Conditions
- Brain Diseases
- Spinal Cord Diseases
Interventions
Gadobutrol~0.03 mmol/kg BW (Gadavist, Gadovist, BAY86-4875)Drug
Participant received one dose of 0.03 mmol/kg BW of Gadobutrol. Gadobutrol was administered via a power injector at a rate of 5 mL/s followed by a 20 mL 0.9% saline flush at the same rate.
Gadobutrol~0.1 mmol/kg BW (Gadavist, Gadovist, BAY86-4875)Drug
Participant received one dose of 0.1 mmol/kg BW of Gadobutrol. Gadobutrol was administered via a power injector at a rate of 5 mL/s followed by a 20 mL 0.9% saline flush at the same rate.
Gadobutrol~0.3 mmol/kg BW (Gadavist, Gadovist, BAY86-4875)Drug
Participant received one dose of 0.3 mmol/kg BW of Gadobutrol. Gadobutrol was administered via a power injector at a rate of 5 mL/s followed by a 20 mL 0.9% saline flush at the same rate.
OptiMARK~0.1 mmol/kg BWDrug
Participant received one dose of 0.1 mmol/kg BW of OptiMARK. OptiMARK was administered via a power injector at a rate of 2 mL/s followed by a 20 mL 0.9% saline flush at the same rate.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Categorical Visualization Score (CVS)Time frame: up to 2 hours after the injection of study medication
- Difference in Number of Lesions Detected in Pre-contrast and Combined Pre-/Post-contrast MRI.Time frame: up to 2 hours after the injection of study medication
- Assessment of Lesion Contrast EnhancementTime frame: up to 2 hours after the injection of study medication
- Assessment of Border DelineationTime frame: up to 2 hours after the injection of study medication
- Assessment of Internal MorphologyTime frame: up to 2 hours after the injection of study medication
- Contrast to Noise Ratio (CNR) Between White and Gray Matter With Gadobutrol Perfusion MRITime frame: up to 2 hours after the injection of study medication
Locations
27 sites in 4 countries. Site status is shown where the registry gives one.
University of California Davis Medical Center
Sacramento, California
University of California-San Diego Medical Center
San Diego, California
Shands Jacksonville Medical Center
Jacksonville, Florida
Emory University School of Medicine
Atlanta, Georgia
Northwestern Memorial Hospital
Chicago, Illinois
Indiana Neuroscience Institute
Indianapolis, Indiana
Johns Hopkins University School of Medicine
Baltimore, Maryland
Boston Medical Center
Boston, Massachusetts
Washington University School of Medicine
St Louis, Missouri
Methodist Hospital
Omaha, Nebraska
NYU Langone Medical Center
New York, New York
University of North Carolina
Chapel Hill, North Carolina
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Temple University Hospital
Philadelphia, Pennsylvania
University of Pittsburgh Medical Center Health System
Pittsburgh, Pennsylvania
Rhode Island Hospital
Providence, Rhode Island
Medical University of South Carolina
Charleston, South Carolina
Methodist Le Bonheur Healthcare
Memphis, Tennessee
University of Washington Medical Center
Seattle, Washington
University of Wisconsin - Madison
Madison, Wisconsin
TCba Salguero
Buenos Aires, Buenos Aires, Argentina
Fundacion Cientifica del Sur
Lornas de Zamora, Buenos Aires, Argentina
Hospital da Beneficiência Portuguesa
São Paulo, São Paulo, Brazil
Fundación Clínica Valle del Lili
Cali, Colombia
Centro de Diagnostico Medico
Medellín, Antioquia, Colombia
Fundación Instituto de Alta tecnología médica de Antioquia
Medellín, Antioquia, Colombia
DIME Clinica Neurocardiovascular S.A.
Cali, Valle del Cauca Department, Colombia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.